AdaptHealth Corp. (AHCO)

NASDAQ: AHCO · USD

$6.04

+0.18 (+3.2%)· Recorded snapshot

Market cap	805.1M
Revenue (ttm)	3.4B
Net income (ttm)	-227.6M
EPS (ttm)	-$1.68
Shares out	133.4M
Volume	1,224,066
Beta	1.42

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 3.4B
Net income (ttm): -227.6M
EPS (ttm): -$1.68
Market cap: 805.1M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Trzymaj

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-15.2

P25 n/aP50 n/aP75 n/a

ROIC4.6

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All AHCO indicators

Market & fundamental data

Available fields

236

Groups with data

Currency

USD

Showing 236 of 236 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001725255
Company name	AdaptHealth Corp.
Country	United States
Country code	US
CUSIP number	00653Q102
Earnings date	2026-11-03
Earnings time	bmo
Employees	10,900
Employees change	400
Employees growth	3.81%
Enterprise value	$2.8B
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2012
In index	RUSSELL2000
Industry	Medical Devices
Is primary listing	Yes
Is SPAC	No
ISIN number	US00653Q1022
Last 10-K release date	2026-02-24
Last earnings date	2026-08-04
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$805.1M
Market cap category	Small-Cap
Next earnings date	2026-11-03
Options	Yes
Price	$6.04
Price currency	USD
Sector	Healthcare
SIC code	8082
Stock price date	2026-10-28
Symbol	AHCO
U.S. state	Pennsylvania
Website	https://adapthealth.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Adjusted P/E ratio	15.64x
Earnings yield	-27.8%
EV/EBIT	17.84x
EV/EBITDA	4.85x
EV/FCF	28.95x
EV/Sales	0.84x
FCF / EV yield	3.45%
FCF yield	12.12%
Forward EV/Sales	0.95x
Forward P/S	0.27x
Industry forward P/E	19.74x
Industry P/E	39.16x
P/(FCF - SBC) ratio	10.72x
P/(OCF - SBC) ratio	1.44x
P/B ratio	0.57x
P/FCF ratio	8.25x
P/OCF ratio	1.38x
P/S ratio	0.24x
Price/EBITDA ratio	1.38x
Sector forward P/E	23.56x
Sector P/E	50.08x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	4.71%
EBITDA margin	17.35%
FCF margin	2.9%
Gross margin	19.18%
Operating margin	4.71%
Pretax margin	-6.98%
Profit margin	-6.79%
Profit per employee	$-20,881
Revenue per employee	$308,568
ROA	2.28%
ROA (5Y)	3.41%
ROCE	4.36%
ROE	-15.22%
ROE (5Y)	-3.67%
ROIC	4.61%
ROIC (5Y)	5.81%
SBC / revenue	0.67%
Tax / revenue	-0.23%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	0
FCF growth	-57.75%
FCF growth 3Y	65.12%
FCF growth 5Y	-4.66%
Gross profit growth	-2.97%
Gross profit growth (Q)	-15.95%
Gross profit growth 3Y	10.6%
Gross profit growth 5Y	12.48%
Net income growth years	0
OCF growth	5.6%
OCF growth (Q)	-10.3%
OCF growth (QoQ)	55.04%
OCF growth 3Y	10.65%
OCF growth 5Y	20.22%
Operating income growth	-23.35%
Operating income growth (Q)	-81.37%
Operating income growth 3Y	-7.32%
Operating income growth 5Y	-3.81%
Revenue growth	13.47%
Revenue growth (Q)	12.66%
Revenue growth (QoQ)	8.89%
Revenue growth 3Y	3.04%
Revenue growth 5Y	14.01%
Revenue growth quarters	2
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-485.6M
Depreciation and amortization	$425M
EBIT	$158.5M
EBITDA	$583.5M
EPS	$-1.68
FCF per share	$0.73
Financing cash flow	$15.8M
Free cash flow	$97.7M
Free cash flow minus SBC	$75.1M
Gross profit	$644.9M
Income taxes	$-7.8M
Investing cash flow	$-624.4M
Net borrowing	$56.8M
Net cash flow	$-25.3M
Net income	$-227.6M
Operating cash flow minus SBC	$560.7M
Operating income	$158.5M
Revenue	$3.4B
Stock-based compensation	$22.5M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	0.94
Book value per share	$10.34
Debt / EBITDA	3.14
Debt / equity	1.49
Debt / FCF	21.14
Goodwill	$2.4B
Interest coverage	1.56
Long-term assets	$3.5B
Long-term liabilities	$2.2B
Net cash (debt)	$-2B
Net cash / market cap	-250.91%
Net debt / EBITDA	3.47
Net debt / equity	1.46
Net debt / FCF	20.7
Piotroski F-Score	5
Property, plant and equipment	$828.4M
Shareholders' equity	$1.4B
Tangible book value	$-1B
Tangible book value per share	$-7.68
Total assets	$4.3B
Total cash	$43.3M
Total debt	$2.1B
Total liabilities	$3B
WACC	6.18%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.77
Current assets	$797.5M
Current liabilities	$709.2M
Current ratio	1.12
Inventory turnover	21.38
Net working capital	$108.5M
Quick ratio	0.64
Working capital	$88.3M
Working capital turnover	54.17

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-0.4%
Dividend yield	0%
Shareholder yield	-0.4%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$8.94
1D price change	3.16%
1M price change	5.5%
1M total return	5.5%
1W price change	-2.46%
1W total return	-2.46%
1Y price change	-36.77%
1Y return CAGR	-36.79%
1Y total return	-36.77%
20-day SMA	$6.00
200-day SMA	$9.24
3M price change	-45.71%
3M total return	-45.71%
3Y price change	-19.59%
3Y return CAGR	-7.01%
3Y total return	-19.59%
50-day SMA	$5.87
50-day SMA vs 200-day SMA	50under200
52-week high	$13.43
52-week high date	2026-05-04
52-week low	$5.21
52-week low date	2026-08-10
5Y price change	-76.62%
5Y return CAGR	-25.23%
5Y total return	-76.62%
6M price change	-54.51%
6M total return	-54.51%
All-time high	$41.58
All-time high date	2021-02-01
All-time low	$5.21
All-time low date	2026-08-10
Average true range (ATR)	$0.26
Average volume	2.1M
Beta (1Y)	-1.29
Beta (2Y)	-0.09
Beta (5Y)	1.42
Change from 52-week high	-55.06%
Change from 52-week low	15.84%
Change from all-time high	-85.69%
Change from all-time low	14.2%
Change from open	3.16%
Day's gap	0%
Dollar volume	$7.4M
High price	$6.08
Low price	$5.85
Monthly RSI	38.01
Open price	$5.85
Position in 52-week range	80.43%
Premarket change	0%
Premarket close	$5.85
Premarket price	$5.85
Previous close	$5.85
Price vs 150-day SMA	-33.43%
Price vs 20-day SMA	-0.77%
Price vs 200-day SMA	-35.59%
Price vs 50-day SMA	1.43%
Relative volume	0.58
RSI	48.04
Sharpe ratio	-0.45
Sharpe ratio (3Y)	0.13
Sharpe ratio (5Y)	-0.24
Sortino ratio	-0.47
Sortino ratio (3Y)	0.27
Sortino ratio (5Y)	-0.24
Volume	1.2M
Weekly RSI	34.69
YTD price change	-40.26%
YTD total return	-40.26%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	85.8M
Float percentage	64.29%
Shares change (QoQ)	0.25%
Shares change (YoY)	0.4%
Shares held by insiders	8.42%
Shares held by institutions	73.96%
Shares outstanding	133.4M
Short % of float	11.18%
Short % of shares	7.19%
Short ratio	3.5 days

Deeper analysis on AHCO

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this AHCO report

Is a complete AHCO research report available?

No complete published report is available for AdaptHealth Corp. (AHCO) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

AdaptHealth Corp. (AHCO)

Price

Financial snapshot

Fair-value bridge

Latest news · AHCO

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All AHCO indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on AHCO

Frequently asked questions